Assurance Infusion recalls BPC-157 2000 mcg/mL 5mL vials due to lack of sterility assurance. Affected lots expire 02/11/2020 and 02/13/2020.
Lack of sterility assurance.
Assurance Infusion is recalling BPC-157 2000 mcg/mL 5mL vials because they may not be sterile. This could lead to infections if used improperly.
The vials may not be sterile, which can cause infections if the medication is injected. This is a serious risk for medical treatments.
People who purchased these vials for medical use are affected. Those with compromised immune systems face higher infection risks.
Check for vials with lot numbers 11132019, 12112019, or 11202019. These vials expire by February 11, 2020 or February 13, 2020.
Look for lot numbers 11132019, 12112019, or 11202019 on the vial.
The recall number is not stated in the official notice.
Check the lot number on the vial; affected lots are 11132019, 12112019, or 11202019.
The official notice does not specify a remedy for affected vials.
We’ve drafted a message you can send Assurance Infusion to request your refund or repair — edit it as you like.
Subject: Recall D-0679-2020 — Assurance Infusion Assurance Infusion Hello, I own a Assurance Infusion that is covered by recall D-0679-2020 from Assurance Infusion. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
